{
    "2019-05-03": [
        [
            {
                "time": "2019-04-25",
                "original_text": "Novo Nordisk A/S (NVO) Q1 2019 Earnings Call Transcript",
                "features": {
                    "keywords": [
                        "Earnings Call",
                        "Q1 2019",
                        "Novo Nordisk"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-25",
                "original_text": "Novo Nordisk (NVO) Q1 Earnings and Revenues Miss Estimates",
                "features": {
                    "keywords": [
                        "Earnings Miss",
                        "Revenues Miss",
                        "Q1"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-04-30",
                "original_text": "Gilead (GILD) Earnings Beat, Revenues Miss Estimates in Q1",
                "features": {
                    "keywords": [
                        "Earnings Beat",
                        "Revenues Miss",
                        "Q1"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-05-02",
                "original_text": "The Daily Biotech Pulse: Obseva Reports Positive Endometriosis Drug Trial, Assembly Biosciences Execs Depart, Coherus Settles With Amgen",
                "features": {
                    "keywords": [
                        "Positive Drug Trial",
                        "Execs Depart",
                        "Settles With Amgen"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}